Global Peripheral Artery Revascularisation Market Report By Product (Lower Extremity Revascularisation, Renal Arterial Revascularisation, Mesenteric Arterial Revascularisation, Abdominal Aortic Revascularisation, Others), By Distribution Channel (Hospitals, Specialty Clinics, Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2022-2030
The global demand for Peripheral Artery Revascularisation Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028.
Peripheral artery disease refers to atherosclerotic occlusive disease of the lower extremities. Other terms used for this disorder are peripheral arterial occlusive disease, peripheral vascular disease, and more moderate extremity arterial disease. The condition can be treated with either surgical and non-surgical options or a combination of both. Peripheral artery revascularization is performed to treat limb ischemia or prevent major limb ischemic events. Revascularization can be performed endovascular or surgical. New promising treatment options such as gene therapy and others are under research; the study's positive response will favor its popularity.
The rising global prevalence of peripheral artery disease (PAD) and the growing aging population contribute to the significant growth of the peripheral artery revascularisation market. Peripheral arterial disease (PAD) is an important manifestation of atherosclerosis, which in 2015 was estimated to affect more than 236.5 million people worldwide. The number of people with the disease is projected to increase at a double-digit rate with high prevalence in low- and high-income countries. With the aging of the global population and the incidence of risk factors such as diabetes, hypertension, obesity, and tobacco use, it seems likely that PAD will be increasingly common in the future. The burden appears to be higher among men than women for more severe or symptomatic disease. Despite a considerable burden and high-risk equivalent, these patients are overlooked, and only one-fourth of patients are submitted to treatment. There is a lack of interest in the routine examination of the PAD, which hinders the market's growth.
The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of peripheral artery revascularisation.
The entire peripheral artery revascularisation market has been sub-categorized into product and distribution channel. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
Lower Extremity Revascularisation
Renal Arterial Revascularisation
Mesenteric Arterial Revascularisation
Abdominal Aortic Revascularisation
By Distribution Channel
This section covers regional segmentation which accentuates on current and future demand for peripheral artery revascularisation market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Peripheral Artery Revascularisation Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the peripheral artery revascularisation market include Abbott Laboratories, Cardinal Health, C. R. Bard, Medtronic, Cook Medical, AngioDynamics, Boston Scientific Corporation, Terumo Corporation, Philips Healthcare. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
1 . PREFACE
1.1. Report Description
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Peripheral Artery Revascularisation Market
2.2. Global Peripheral Artery Revascularisation Market Snapshot
3 . PERIPHERAL ARTERY REVASCULARISATION – INDUSTRY ANALYSIS
3.2. Market Drivers of Peripheral Artery Revascularisation Market
3.3. Market Restraints of Peripheral Artery Revascularisation Market
3.4. Opportunities of Peripheral Artery Revascularisation Market
3.5. Trends of Peripheral Artery Revascularisation Market
3.6. Porter's Five Force Analysis of Peripheral Artery Revascularisation Market
3.7. Peripheral Artery Revascularisation Market Attractiveness Analysis
3.7.1 Market Attractive Analysis by Product
3.7.2 Market Attractive Analysis by Distribution Channel
3.7.3 Market Attractive Analysis by Region
4 . VALUE CHAIN ANALYSIS
4.1. Peripheral Artery Revascularisation Value Chain Analysis
4.2. Peripheral Artery Revascularisation Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Peripheral Artery Revascularisation Raw Material Manufactures List
4.2.3. Price Trend of Peripheral Artery Revascularisation Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 IMPACT ANALYSIS OF COVID-19 OUTBREAK
5.1. Impact Analysis of Covid-19 Outbreak on Peripheral Artery Revascularisation Ma ...